Martinjak, V.; Večenaj, L.; Hofer, R.; Tomić, F.; Lastovčić, D.; Babić Visković, B.; Ašperger, D.; Cvetnić, M.; Kučić Grgić, D.; Bolanča, T.;
et al. Forced Degradation Study of Atazanavir, Emtricitabine, Nirmatrelvir, Oseltamivir, Ribavirin and Sofosbuvir. Environments 2025, 12, 417.
https://doi.org/10.3390/environments12110417
AMA Style
Martinjak V, Večenaj L, Hofer R, Tomić F, Lastovčić D, Babić Visković B, Ašperger D, Cvetnić M, Kučić Grgić D, Bolanča T,
et al. Forced Degradation Study of Atazanavir, Emtricitabine, Nirmatrelvir, Oseltamivir, Ribavirin and Sofosbuvir. Environments. 2025; 12(11):417.
https://doi.org/10.3390/environments12110417
Chicago/Turabian Style
Martinjak, Viktorija, Luka Večenaj, Roberta Hofer, Filip Tomić, Dora Lastovčić, Bruna Babić Visković, Danijela Ašperger, Matija Cvetnić, Dajana Kučić Grgić, Tomislav Bolanča,
and et al. 2025. "Forced Degradation Study of Atazanavir, Emtricitabine, Nirmatrelvir, Oseltamivir, Ribavirin and Sofosbuvir" Environments 12, no. 11: 417.
https://doi.org/10.3390/environments12110417
APA Style
Martinjak, V., Večenaj, L., Hofer, R., Tomić, F., Lastovčić, D., Babić Visković, B., Ašperger, D., Cvetnić, M., Kučić Grgić, D., Bolanča, T., & Ukić, Š.
(2025). Forced Degradation Study of Atazanavir, Emtricitabine, Nirmatrelvir, Oseltamivir, Ribavirin and Sofosbuvir. Environments, 12(11), 417.
https://doi.org/10.3390/environments12110417
